Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Chronic Lymphocytic Leukemia Patients
.
Show all posts
Showing posts with label
Chronic Lymphocytic Leukemia Patients
.
Show all posts
Friday, October 11, 2019
AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients
›
In continuation of my update on Venclexta (venetoclax) AbbVie a research-based global biopharmaceutical company, announced th...
›
Home
View web version
